Sort
64,565 grants matching “drug discovery”
Chemical, Structural and Cell-Signaling Interrogation of 15-Prostanglandin Dehydrogenase in Tissue Repair and Regeneration
$1,354,462Joseph M Ready · Ut Southwestern Medical Center · RM1 · FY2023 · GM
Chemical, Structural and Cell-Signaling Interrogation of 15-Prostanglandin Dehydrogenase in Tissue Repair and Regeneration
$1,354,462Joseph M Ready · Ut Southwestern Medical Center · RM1 · FY2025 · GM
Discovery to Implementation & Back: Research Translation for the HIV/SU Epidemic
$1,354,410Sherry Deren · New York University · P30 · FY2017 · DA
Biased Agonism In GPCR Drug Discovery: Application To Somatostatin Agonists
$1,354,308Richard Scott Struthers · Crinetics Pharmaceuticals, Inc. · R44 · FY2018 · DK
Cellular and Molecular Physiology of Bloodstream Malaria Parasites
$1,353,586Sanjay A Desai · National Institute Of Allergy And Infectious Diseases · ZIA · FY2022 · AI
High Throughput Screening for Ligands for Seven Transmembrane-spanning Receptors
$1,353,500Marvin Gershengorn · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIA · FY2018 · DK
Signaling Aberrations and Cerebral Cavernous Malformation Pathogenesis
$1,353,471Douglas A Marchuk · Duke University · P01 · FY2020 · NS
San Antonio Claude D. Pepper Older Americans Independence Center
$1,353,062Nicolas Musi · University Of Texas Hlth Science Center · P30 · FY2021 · AG
COVID-19: Identification and Development of Clinical Candidates to Treat SARS-CoV-2
$1,352,770Donald Lo · National Center For Advancing Translational Sciences · ZIA · FY2021 · TR
Human Melanoma: Etiology, Progression and Therapy
$1,352,759Meenhard Herlyn · Wistar Institute · P01 · FY2013 · CA
Development of positive TMEM97 modulators for treating neuropathic pain
$1,352,240Stephen Martin · Nuvonuro Inc · UG3 · FY2023 · NS
Whole Genome Sequencing to Identify Causal Genetic Variants Influencing CVD Risk
$1,351,969John Blangero · Texas Biomedical Research Institute · R01 · FY2014 · HL
Clinical and biomarker studies in Alzheimer's disease and related disorders
$1,351,606Dimitrios Kapogiannis · National Institute On Aging · ZIA · FY2022 · AG
Chemoprevention of Skin Cancer Program Project
$1,351,432David S Alberts · University Of Arizona · P01 · FY2011 · CA
MICROSCALED PROTEOGENOMICS FOR CANCER CLINICAL TRIALS
$1,351,343Matthew J Ellis · Baylor College Of Medicine · U01 · FY2019 · CA
Customized stem cells for clinical application in blood disorders
$1,350,804George Q Daley · Boston Children'S Hospital · R24 · FY2017 · DK
Inhibition Of Renal Injury
$1,350,803Robert A Star · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIA · FY2024 · DK
Biomolecular Structure and Mechanism, Structure-Based Drug Design
$1,350,391Xinhua Ji · Division Of Basic Sciences - Nci · ZIA · FY2011 · CA
Center for Computational Mass Spectrometry
$1,350,362Pavel A Pevzner · University Of California, San Diego · P41 · FY2015 · GM
Clark Atlanta University Biomedical Science Development
$1,350,233Carlton E. Brown · Clark Atlanta University · G12 · FY2008 · RR
02 Research Animal Support Facility-Houston/Smithville
$1,349,913Vanessa Jensen · University Of Tx Md Anderson Can Ctr · P30 · FY2023 · CA
02 Research Animal Support Facility-Houston/Smithville
$1,349,913Vanessa Jensen · University Of Tx Md Anderson Can Ctr · P30 · FY2019 · CA
02 Research Animal Support Facility-Houston/Smithville
$1,349,913Vanessa Jensen · University Of Tx Md Anderson Can Ctr · P30 · FY2021 · CA
02 Research Animal Support Facility-Houston/Smithville
$1,349,913Vanessa Jensen · University Of Tx Md Anderson Can Ctr · P30 · FY2022 · CA
Pathogen-specific drug targets for weaponized bacteria
$1,349,740Rockefeller University · U19 · FY2005 · AI